Lean Toward Tirofiban or Eptifibatide When Bridging During DAPT Interruption

September 2017

Some coronary stent patients will undergo IV antiplatelet bridging when oral dual antiplatelet therapy (DAPT) is interrupted.

Stopping DAPT within the first month after placing a bare-metal stent or 6 months after a drug-eluting stent can be tricky...due to increased risk of stent thrombosis.

Many surgeries can be postponed during this time. But urgent surgeries may require that oral DAPT be held during this risky period.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Parkinson's Disease Avoid Adjusting Parkinson's Med Regimens When Patients are Hospitalized
Antiplatelets Lean Toward Tirofiban or Eptifibatide When Bridging During DAPT Interruption
Med Safety Compound Oral Liquid Meds Using New National Standard Concentrations
Anticoagulants Don't Jump to DOACs First-Line for Cancer-Related VTE
Dermatology Know How to Handle MRIs, Med Administration, and Cellulitis With Tattoos
Hypertension Watch for Commonly Used Meds That May Increase Blood Pressure
Liver Disease Optimize Meds for Comorbidities in Nonalcoholic Fatty Liver Disease
Neurology & Pain Watch for Additive CNS Effects With Diabetic Peripheral Neuropathy Meds
Cannabinoids Be Familiar With Acute Marijuana Toxicity...and How to Treat It
Multiple Sclerosis Help Safely Transition Patients Receiving Multiple Sclerosis Meds at Home
Storage & Disposal Don't Break the Cold Chain With Refrigerated and Frozen Meds
New Drugs Feel Comfortable Holding the Postmenopausal Med Intrarosa on Admission

Lean Toward Tirofiban or Eptifibatide When Bridging During DAPT Interruption

Get unlimited access through an Enterprise license

Table of Contents